Furthermore, reducing or preventing intramuscular lipid accumulation increases insulin sensitivity. The implications of these results should be clear and having read the previous portions of this article and examined the figures, self-explanatory
Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
Its all tailored to your body, your cycle, and your long-term health goals
10.1016/0165-1218(84)90081-8 Mutat
Furthermore, systematic clinical evidence regarding the long-term impact of GLP-1RAs on cancer risk is lacking, creating challenges for assessing the long-term safety of these treatments
Albers AC, Gutmann DH